September 2005
Worldwide Biotech;Sep2005, Vol. 17 Issue 9, p7
Trade Publication
Focuses on Incyte Corporation's randomized double-blind phase IIb trial of Reverset in treatment-experienced HIV infected patients. Number of patients and clinical sites involved in the study; Preliminary results from the trial on Reverset's efficacy; Stages of the study's protocol.


Related Articles

  • Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals. Clifford, David B.; Evans, Scott; Yijun Yang; Acosta, Edward P.; Goodkin, Karl; Tashima, Karen; Simpson, David; Dorfman, David; Ribaudo, Heather; Gulick, Roy M. // Annals of Internal Medicine;11/15/2005, Vol. 143 Issue 10, p714 

    Background: Efavirenz is a commonly used antiretroviral drug that causes neurologic side effects in more than 50% of patients. Objective: To characterize efavirenz-associated neurologic symptoms in a randomized, controlled study of initial antiretroviral treatment. Design: Substudy of a...

  • A Randomized Trial of Directly Administered Antiretroviral Therapy and Adherence Case Management Intervention. Wohl, Amy Rock; Garland, Wendy H.; Valencia, Rosa; Squires, Kathleen; Witt, Mallory D.; Kovacs, Andrea; Larsen, Robert; Hader, Shannon; Anthony, Monique-Nicole; Weidle, Paul J. // Clinical Infectious Diseases;6/1/2006, Vol. 42 Issue 11, p1619 

    Background. A randomized, controlled trial was conducted to evaluate the impact of a directly administered antiretroviral therapy program (DAART) and intensive adherence case management (IACM) intervention on virologic and immunologic response to highly active antiretroviral therapy (HAART)...

  • Resistance study to re-evaluate HAART. Kenyon, Georgina // Nature Medicine;May2001, Vol. 7 Issue 5, p515 

    Reports on the international trial to determine the effectiveness of the treatment for AIDS patients for failure of triple therapy on them. Development of HIV resistance to antiretroviral therapy (HAART); Increase in the global management of drug regime; Evaluation of the benefits for the...

  • Long-Term Responses to Treatment including Ritonavir or Nelfinavir in HIV-1-Infected Children. Nadal, D.; Steiner, F.; Cheseaux, J.-J.; Lazarevitch, C.-A.Wyler; Aebi, C.; Kind, C.; Rudin, C. // Infection;Oct2000, Vol. 28 Issue 5, p287 

    Background: Knowledge concerning the long-term antiretroviral and immunological efficacy of protease inhibitors in children is limited. Patients and Methods: An open-label, prospective, multicenter clinical trial was conducted over a period of 72 weeks in Switzerland. 60 HIV-1 infected children...

  • TREATMENT BRIEFS.  // HIV Australia;2007, Vol. 7 Issue 1, p41 

    The article focuses on two international clinical trials of the drug interleukin-2 (IL-2, Proleukin) in Human Immunodeficiency Virus (HIV) afflicted people which had produced no result. IL-2 is reportedly a natural substance produced by T-cells that stimulates the production of CD4 T-cells. The...

  • Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study. Manuel, Oriol; Husain, Shahid; Kumar, Deepali; Zayas, Carlos; Mawhorter, Steve; Levi, Marilyn E.; Kalpoe, Jayant; Lisboa, Luiz; Ely, Leticia; Kaul, Daniel R.; Schwartz, Brian S.; Morris, Michele I.; Ison, Michael G.; Yen-Lieberman, Belinda; Sebastian, Anthony; Assi, Maha; Humar, Atul // Clinical Infectious Diseases;Mar2013, Vol. 56 Issue 6, p817 

    In high-risk solid-organ transplant recipients receiving antiviral prophylaxis, the measurement of specific cell-mediated immunity using the Quantiferon assay appropriately stratified the individual risk of developing subsequent cytomegalovirus disease.Background. Cytomegalovirus (CMV) disease...

  • Strategies for Initiating Combination Antiretroviral Therapy. Michael L.#Tapper; Eric S.#Daar; Peter J.#Piliero; Kimberly#Smith; Corklin#Steinhart // AIDS Patient Care & STDs;Apr2005, Vol. 19 Issue 4, p224 

    Numerous potent antiretroviral regimens have proven successful as initial therapy in treat- ment-naïve HIV-infected patients. As the development of new agents makes possible new treatment regimens, providers are faced with increasingly complex questions of when to initiate treatment and which...

  • Impact of a Massage Therapy Clinical Trial on Immune Status in Young Dominican Children Infected with HIV-1. Shor-Posner, Gail; Hernandez-Reif, Maria; Miguez, Maria-Jose; Fletcher, Maryann; Quintero, Noaris; Baez, Jeanette; Perez-Then, Eddy; Soto, Solange; Mendoza, Rosangela; Castillo, Raquell; Guoyan Zhang // Journal of Alternative & Complementary Medicine;Jul/Aug2006, Vol. 12 Issue 6, p511 

    Purpose: The effectiveness of massage therapy on immune parameters was evaluated in young Dominican HIV+ children without current access to antiretroviral therapies. Methods: Eligible children, who were followed at the Robert Reid Cabral Hospital (San Domingo, Dominican Republic), were...

  • Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir. Theys, K.; Snoeck, J.; Vercauteren, J.; Abecasis, A. B.; Vandamme, A.-M.; Camacho, R. J. // Journal of Antimicrobial Chemotherapy (JAC);Feb2013, Vol. 68 Issue 2, p419 

    Objectives The use of tenofovir is highly associated with the emergence of mutation K65R, which confers broad resistance to nucleoside/nucleotide analogue reverse transcriptase inhibitors (NRTIs), especially when tenofovir is combined with other NRTIs also selecting for K65R. Although recent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics